Trials / Sponsors / Alexander B Olawaiye, MD
Alexander B Olawaiye, MD
Academic / Other · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination De Ovarian Cancer | Phase 2 | 2024-01-17 |
| Recruiting | ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | Phase 2 | 2023-04-21 |
| Active Not Recruiting | Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurr Ovarian Cancer | Phase 2 | 2023-03-30 |
| Recruiting | T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors Epithelial Ovarian Cancer | Phase 1 / Phase 2 | 2022-09-30 |